RxDoctor Payments Data

Jennifer Sullivan

Nurse Practitioner · Dublin, OHNPI 1699042150

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 143 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by AbbVie at 39.3% of the total. Reporting peaked in 2022 at $911 and has fallen 84.1% since, to $145 in 2025. Among nurse practitioner clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,226in general payments, 2019–2025

Across 143 payments — averaging $15.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$875
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$703
  • Collegium Pharmaceutical, Inc.$127
  • Biohaven Pharmaceutical Holding Company Ltd.$121
  • Pfizer$115
  • Boston Scientific$61
  • plus $223 from 9 others

What the payments were for

  • Food & beverage$2,226100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,226 in reported general payments places this provider in the 90th percentile of 4,700 nurse practitioner providers in Ohio.

See all nurse practitioner providers in Ohio →

Medicare billing

Part B allowed, 2024
$4,643
Medicare patients
40
Services billed
66

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl93$2,631
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen91$2,189
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen57$2,041
Morphine Sulfate ErMorphine Sulfate23$1,389
Celecoxib23$697
Pregabalin41$669
Gabapentin33$534
Cyclobenzaprine Hcl19$230
Tramadol Hcl17$196
Tizanidine Hcl24$169
Zolpidem Tartrate22$56

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Dublin

See the full list for Ohio →

Where these figures come from

Is this you, or does something look wrong? →